Tiny radioactive tracer reveals Drug's journey through the body
NCT ID NCT07494175
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This early-stage study tracks a single injection of [14C]HRS-9190 in 6 healthy men to see how it is absorbed, broken down, and eliminated. The goal is to understand the drug's metabolism and excretion, not to treat any disease. Participants are closely monitored for side effects, but there is no expected health benefit.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- [14C]HRS-9190 (a radioactive-labeled drug for injection)
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY ADULT MALE are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
First Affiliated Hospital of Shandong First Medical University (Shandong Provincial Qianfoshan Hospital)
Jinan, Shandong, 250014, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a simple vest make breathing easier?
- Chilly workouts may alter what you eat, small study suggests
- New Parkinson's drug MF1 enters first human safety trial
- AI-Powered training cuts hamstring injury risk in pro footballers
- Beta-Alanine boost for cyclists? new study reveals mixed results
- New Egg-Maturing technique could help women with low IVF success